Report: EU Country Cancer Profile 2023 (Belgium): Difference between revisions
From Beacon
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
Go back to [[Belgium]] page | Go back to [[Belgium]] page | ||
''' | '''Primary purpose:''' To provide reliable data on cancer prevention and care, identifying trends, disparities, and inequalities among EU Member States and regions to guide interventions under Europe's Beating Cancer Plan. | ||
''' | '''Sponsor, manager or home institution:''' [[dataOwner::OECD and European Commission]]. | ||
'''Type of information:''' National cancer burden; Cancer incidence and mortality; Risk factors for cancer; Early detection programs (screenings); Cancer care performance, The impact of COVID-19 on cancer care. | '''Type of information:''' National cancer burden; Cancer incidence and mortality; Risk factors for cancer; Early detection programs (screenings); Cancer care performance, The impact of COVID-19 on cancer care. | ||
'''Data level''': | '''Data level''': [[dataLevel::national level]]. | ||
'''Cancer areas of interest:''' | |||
'''Access to information:''' | '''Access to information:''' [https://www.oecd-ilibrary.org/social-issues-migration-health/landenprofiel-voor-kanker-belgie-2023_1700ff9f-nl Click here to access]. | ||
Revision as of 17:01, 30 April 2024
Go back to Belgium page
Primary purpose: To provide reliable data on cancer prevention and care, identifying trends, disparities, and inequalities among EU Member States and regions to guide interventions under Europe's Beating Cancer Plan.
Sponsor, manager or home institution: OECD and European Commission.
Type of information: National cancer burden; Cancer incidence and mortality; Risk factors for cancer; Early detection programs (screenings); Cancer care performance, The impact of COVID-19 on cancer care.
Data level: national level.
Cancer areas of interest:
Access to information: Click here to access.
